# A Study Aiming to Demonstrate That the Addition of Intravenous (IV) Tranexamic Acid-Compared to Placebo-During Anterior Cruciate Ligament (ACL) Reconstruction Results in Reduced Blood Loss and Postoperative Pain.

> **NCT07753161** · NA · COMPLETED · sponsor: **GCS Ramsay Santé pour l'Enseignement et la Recherche** · enrollment: 100 (actual)

## Conditions studied

- Ligamentoplasty
- Hemoglobin

## Interventions

- **PROCEDURE:** ACL reconstruction

## Key facts

- **NCT ID:** NCT07753161
- **Lead sponsor:** GCS Ramsay Santé pour l'Enseignement et la Recherche
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-03
- **Primary completion:** 2024-11-04
- **Final completion:** 2025-06-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753161, "A Study Aiming to Demonstrate That the Addition of Intravenous (IV) Tranexamic Acid-Compared to Placebo-During Anterior Cruciate Ligament (ACL) Reconstruction Results in Reduced Blood Loss and Postoperative Pain.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07753161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*